Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 18 - What They Never Told You

Key Ingredient In Weight Loss Drugs Ozempic And Wegovy Cuts Risk Of COVID Death: Report

People being treated with the drugs, which both contain semaglutide, had a 33% lower risk of dying from the disease, study found

International Business Times

3 Mega-Cap Stocks Not Named Nvidia Up More than 40% in 2024

3 Mega-Cap Stocks Not Named Nvidia Up More than 40% in 2024

Shares of mega-cap stocks such as Walmart, Meta Platforms, and Eli Lilly have surged over 40% in 2024, outpacing the broader markets by a wide margin.

Eli Lilly Launches Discount Anti-Obesity Drug

Eli Lilly Launches Discount Anti-Obesity Drug

The company claims the Zepbound doses cost 50% less than competing drugs

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Weight loss drug Tirzepatide cuts diabetes risk by an astonishing 94%, says study

A new study on the popular weight loss drug Tirzepatide, manufactured by American pharmaceutical company Eli Lilly, has found the drug could dramatically cut the risk of developing type 2 diabetes in obese or overweight people with prediabetes, compared with a placebo.

The Times of India

Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results

The three-year trial results revealed that a once-a-week tirzepatide injection for adults who are prediabetic, obese, or overweight reduced their risk of progressing to type 2 diabetes by 94%.

Stocks Finish Lower as Chip and Energy Stocks Decline

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.24%. US stocks Tuesday gave up an early advance and posted modest losses. Weakness in...

Eli Lilly Weight-loss Drugs Cut Long-term Diabetes Risk: Study

Weight-loss drugs produced and distributed by Eli Lilly show promising results in cutting long-term diabetes risk.

International Business Times

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks Pressured by Chip Stocks and Diabetes Device Makers

Stocks Pressured by Chip Stocks and Diabetes Device Makers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.32%. US stocks today gave up an early advance and turned lower. Weakness in chip...

Stocks Waver as the Market Awaits Clues From the Fed About Interest Rates

Stocks Waver as the Market Awaits Clues From the Fed About Interest Rates

The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. US stocks today are slightly lower this morning, despite a decline in T-note yields....

Stocks See Support from Lower Bond Yields and Positive Corporate News

Stocks See Support from Lower Bond Yields and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.22%. US stocks today are mostly higher, with the S&P 500 climbing to a 1-month...

Up 58% YTD, is Eli Lilly Stock Still a Buy?

Up 58% YTD, is Eli Lilly Stock Still a Buy?

The pharmaceutical giant has already delivered massive gains this year, but Wall Street analysts have only gotten more bullish on the maker of Mounjaro and Zepbound.

5 'Strong Buy' Stocks That Just Reported Killer Earnings

5 'Strong Buy' Stocks That Just Reported Killer Earnings

As the earnings season nears its close, here are five ‘Strong Buy’-rated stocks that delivered exceptional earnings results.

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly has significantly outperformed the broader market over the past year, and Wall Street analysts are bullish about the stock’s prospects.

Stocks Rally Sharply on Positive US Labor Market News

Stocks Rally Sharply on Positive US Labor Market News

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +2.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.06%. US stocks on Thursday settled sharply higher. Stocks rallied Thursday after US weekly initial...

Get all your
news in one place.

100's of premium titles.
One news app.

Stock Market Today: Stocks Rally as Recession Fears Ease

Initial jobless claims fell more than expected last week, which helped calm fears of a slowing labor market.

Stocks Rally as Economic Concerns Ease and Chip Stocks Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.24%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

Eli Lilly's Weight-Loss Drugs Fuel Beat-And-Raise Quarter

Eli Lilly stock is surging after the pharma giant beat Q2 estimates and lifted its full-year outlook. Here's what you need to know.

Stocks Climb as US Weekly Jobless Claims Ease Economic Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +0.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Novo Nordisk cuts profit outlook after weaker sales of weight-loss drug Wegovy

Danish company, which also makes Ozempic, faces increasing competition from US rival Eli Lilly

1 Billionaire-Backed Penny Stock With 421% Upside

Down 96% from all-time highs, AbCellera Biologics is a biotech stock with massive upside potential, given consensus price target estimates.

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Should You Buy These Stocks Before They Join The $1 Trillion Market Cap Club?

Their strong fundamentals, brand strength, and drive to succeed could propel their stock higher.

3 Healthcare Innovators With Game-Changing Treatments

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, rising R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks, Eli Lilly (LLY), Bristol-Myers (BMY), and Merck & Co. (MRK), which look poised for blockbuster…

3 Leading S&P 500 Stocks Set to Climb Even Higher

As the stock market evolves, leading S&P 500 stocks like Eli Lilly and Company (LLY), Howmet Aerospace (HWM), and NetApp (NTAP) are well-positioned to capitalize on current market conditions and climb higher. Read on….

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

Roche is working on bringing its weight-loss medications to patients "faster than anticipated,” making it yet another contender in the weight-loss drug market.

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

366,554 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play